Persistence of Beta-Blocker Treatment After a Heart Attack (PBH)

Assesses adults 18 years of age and older during the measurement year who were hospitalized and discharged alive with a diagnosis of acute myocardial infarction and who received persistent beta-blocker treatment for six months after discharge.

Why It Matters

Every 34 seconds, someone in the United States has a heart attack.¹ A heart attack, or myocardial infarction, occurs when blood flow to the heart is greatly reduced or stops completely.² Clinical guidelines recommend taking a beta-blocker after a heart attack to prevent another heart attack from occurring.³ Beta-blockers work by lowering the heart rate. This reduces the amount of force on the heart and blood vessels.4 Persistent use of a beta-blocker after a heart attack can improve survival and heart disease outcomes.

Results – National Averages

Persistence of Beta-Blocker Treatment After A Heart Attack (PBH)

Measure YearCommercial HMOCommercial PPOMedicaid HMOMedicare HMOMedicare PPO

§ Not available due to CMS suspension of data reporting during COVID-19 pandemic.

This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.

Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via for analysis that accounts for trend breaks.


  1. Go, A.S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, et al. 2014. “Heart disease and stroke statistics—2014 update: a report from the American Heart Association.” Circulation 129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80
  2. American Heart Association (AHA). 2016. “About Heart Attacks.”
  3. Yancey, C.W., M. Jessup, B. Bozkurt, J. Butler, D.E. Casey, M.H. Drazner, G.C. Fonarow, et al. 2013. “ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 128:e240–e327.
  4. AHA. 2013. “How do beta blocker drugs affect exercise?”

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.